Parada, Guillermo E.
Munita, Roberto
Georgakopoulos-Soares, Ilias
Fernandes, Hugo J. R.
Kedlian, Veronika R.
Metzakopian, Emmanouil
Andres, Maria Estela
Miska, Eric A.
Hemberg, Martin https://orcid.org/0000-0001-8895-5239
Funding for this research was provided by:
Cancer Research UK (C13474/A18583)
Cancer Research UK (C6946/A14492)
Wellcome Trust (104640/Z/14/Z, 092096/Z/10/Z, -)
Article History
Received: 19 February 2020
Accepted: 15 December 2020
First Online: 22 January 2021
Ethics approval and consent to participate
: Not applicable
: Not applicable
: EAM is a founder and director of STORM Therapeutics.